SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

this coin is scarce

SCARCE CRYPTO is trending as traders discuss its potential for a breakout, citing a tightening chart pattern and signs of accumulation. The community believes the coin exhibits disciplined strength and is coiling for a significant move, with some suggesting it's still early to load up.

GraniteShares ETF Trust - GraniteShares 2x Long MARA Daily ETF

GraniteShares 2x Long MARA Daily ETF

GraniteShares 2x Long MARA Daily ETF (MRAL) is trending as traders discuss its leveraged exposure to MARA, a Bitcoin mining company. Community members are weighing rate cut expectations and upcoming earnings, with some opting to swap MARA shares for MRAL to amplify potential gains. There's considerable chatter about MARA's Bitcoin holdings and potential impact on earnings.

Memecoin on Injective taken over by the community.

Nonja

$NONJA is trending due to its strong community and association with the Injective ($INJ) ecosystem, particularly with the recent EVM mainnet launch on Injective. Community members highlight the coin's burned liquidity, active development, and potential for high returns as key reasons for their bullish sentiment. There is increasing discussion around its potential to outperform as the INJ ecosystem develops.

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Strike Coin

Strike Coin ($STRK) is trending as the community highlights its privacy and scaling solutions, particularly its relationship with Zcash ($ZEC). Discussions focus on Starknet's potential to bring privacy to Layer 2 and its potential for significant rallies.  Some community members are also noting the current ticker may not be Starknet.

CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Cel-Sci Corp.

Cel-Sci Corp

CEL-SCI Corp is trending as investors await a decision from the Saudi Food and Drug Authority (SFDA) regarding Breakthrough Medicine Designation for its drug Multikine. The community is focused on the potential for accelerated approval in Saudi Arabia, a move that could validate the drug's efficacy in a specific patient subgroup and open doors to a new market. Community members debate the likelihood of approval and the implications for the company's financial outlook and confirmatory trial plans.

AltShares Trust - AltShares Merger Arbitrage ETF

ARB is garnering attention due to its increasing integration with Robinhood's tokenization and PayPal's stablecoin initiatives. Community members are actively discussing Arbitrum's potential catalysts and comparing its performance against other layer-2 solutions like Optimism and individual tokens like Floki. The broader narrative focuses on Arbitrum's role in scaling Ethereum and its competition within the layer-2 landscape.

Arbitrum is one of the leading Ethereum scaling solutions bringing cheap transactions to tens of thousands of users in an environment that feels very similar to Ethereum. It is an optimistic rollup and the leading L2 in terms of TVL. Some of the largest dApps live on Arbitrum include GMX, Radiant, Uniswap V3, and Gains Network.

Arbitrum

Arbitrum (ARB) is trending as the community discusses its potential for tokenizing real-world assets, particularly with Robinhood and PayPal utilizing the platform. Discussions revolve around Arbitrum's position as a leading layer-2 solution for Ethereum, offering scalability and efficiency. Some community members are pointing out its undervalued status compared to other blockchains.

Injective is an interoperable Layer 1 blockchain designed for DeFi applications. It provides developers with on-chain financial infrastructure modules to build dApps such as decentralized exchanges, prediction markets, and lending protocols. Its decentralized cross-chain bridging infrastructure offers compatibility with most blockchains, including EVM chains like Ethereum and non-EVM chains like Solana.

Injective

Injective is trending due to the growing buzz around its meme coin, $NONJA, which the community believes offers high growth potential, especially with the recent launch of Injective's EVM mainnet and BlackRock testing tokenized assets on the network. Community members highlight Nonja's strong community, burned liquidity, and potential to outperform $INJ during altseason, positioning it as a leveraged play within the Injective ecosystem.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins ($PENGU) is trending amidst fluctuating prices, sparking intense debate about its potential. The community is weighing bullish prospects like the approaching ETF season against bearish sentiments, with some fearing a continued downtrend. Discussions also include observations of market manipulation, potential buy-in points, and the impact of broader crypto market movements on PENGU's performance.

Kaspa was fair-launched in November 2021 with no pre-mine, zero pre-sale, and no coin allocations, and is 100 percent community-managed. Kaspa aims to be the world's global sequencer for traditional finance and decentralized crypto markets by utilizing proof-of-work and its BlockDAG consensus protocol, GHOSTDAG. Being the world's fastest proof-of-work network, Kaspa combines five properties: (1) hard money principles, (2) Bitcoin's ethos of security-first fundamentals (boasting a security threshold of fifty percent with significant market hashrate), (3) decentralization from rapid block rate mining, (4) block speeds faster than any PoW or PoS network, and (5) smart contract development through based-rollups without fragmented liquidity. Ushering in all five properties, Kaspa is on track to fulfill Satoshi Nakamoto's vision of a digital medium of exchange while also advancing global layer-one sequencing and minuscule confirmation times dominated by internet latency (cf. chapter 6 of the the paper for some initial benchmarks). The Kaspa implementation includes a lot of cool features and subprotocols including Reachability to query the DAG's topology, Block data pruning (with near-future plans for block header pruning), SPV proofs, and later subnetwork support which will make future implementation of layer 2 solutions much easier.

Kaspa

Kaspa is trending as community members analyze accumulation patterns and anticipate potential exchange listings. The focus remains on Kaspa's technology, particularly its speed and scalability, with discussions around its potential to outperform other cryptocurrencies. Some traders are pointing to bullish technical indicators as potential upside catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Twist Bioscience (NASDAQ:TWST) Hits New 1-Year Low Following Weak Earnings

Twist Bioscience (NASDAQ:TWST) Sets New 1-Year Low on Disappointing Earnings...

Twist Bioscience Eyes Profit Turnaround In 2026 After Narrowing Losses

Twist Bioscience reports mixed Q4 earnings with a loss of 45 cents, sales of $99.01 million beating consensus.read more...

Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates

Twist Bioscience (TWST) delivered earnings and revenue surprises of -12.50% and +1.69%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the fourth quarter and full year fiscal 2025...

Top Wall Street Forecasters Revamp Twist Bioscience Expectations Ahead Of Q4 Earnings

MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Lags Revenue Estimates

MeiraGTx (MGTX) delivered earnings and revenue surprises of -24.00% and -89.95%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Ovid Therapeutics (OVID) Reports Q3 Loss, Lags Revenue Estimates

Ovid Therapeutics (OVID) delivered earnings and revenue surprises of -13.33% and -61.18%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Vestmark Advisory Solutions Inc. Has $7.27 Million Position in Twist Bioscience Corporation $TWST

Vestmark Advisory Solutions Inc. lifted its holdings in Twist Bioscience Corporation (NASDAQ:TWST - Free Report) by 117.0% in the 2nd quarter, according to the company in its most recent disclosure...

Twist Bioscience (TWST) Expected to Announce Earnings on Friday

Twist Bioscience (NASDAQ:TWST) will be releasing its Q4 2025 earnings before the market opens on Friday, November 14. (View Earnings Report at...

Lineage Cell (LCTX) Reports Q3 Loss, Tops Revenue Estimates

Lineage Cell (LCTX) delivered earnings and revenue surprises of -550.00% and +40.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

Twist Bioscience Corp

Will NVIDIA ($NVDA) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

) beat quarterly earnings? 
 
*Powered by Polymarket

TWST
Twist Bioscience Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest TWST News

TWSTTwist Bioscience Corp